Abstract:The evolution of "humanized" (i.e., free of animal sourced reagents) and ultimately chemically defined culture systems for human embryo stem cell (hESC) isolation and culture is of importance to improving their efficacy and safety in research and therapeutic applications. This can be achieved by integration of a multitude of individual approaches to replace or eliminate specific animal sourced reagents into a single comprehensive protocol. In the present study our objective was to integrate strategies obviating reliance on some of the most poorly defined and path-critical factors associated with hESC derivation, namely the use of animal immune compliment to isolate embryo inner cell mass, and animal sourced serum products and feeder cells to sustain hESC growth and attachment. As a result we report the derivation of six new hESC lines isolated by outgrowth from whole blastocysts on an extracellular matrix substrate of purified human laminin (Ln) with transitional reliance on mitotically inactivated human fibroblast (HDF) feeder cells. With this integrated system hESC lines were isolated using either HDF conditioned medium supplemented with a bovine-sourced serum replacement (bSRM), or a defined serum-free medium (SFM) containing only human sourced and recombinant protein. Further, outgrowth of embryonic cells from whole blastocysts in both media could be achieved for up to 1 week without reliance on feeder cells. All variant conditions sustained undifferentiated cell status, a stable karyotype and the potential to form cells representative of all three germinal lineages in vitro and in vivo, when transitioned off of feeders onto Laminin or Matrigel. Our study thus demonstrates the capacity to integrate derivation strategies eliminating a requirement for animal immune compliment and serum products, with a transitional requirement for human feeder cells. This represents another sequential step in the generation of therapeutic grade stem cells with reduced risk of zoonotic pathogen transmission.

Derivation of induced pluripotent stem cell lines from New Zealand donors

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Derivation, Characterization and Differentiation of a New Human Embryonic Stem Cell Line from a Chinese Hatched Blastocyst Assisted by a Non-Contact Laser System

Derivation of Ipsc Lines from Three Young Healthy Donors of Caucasian Origin (Nuigi035-A; NUIGi036-A; NUIGi037-A).

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

Three induced pluripotent stem cell lines (TRNDi033-A, TRNDi034-A, TRNDi035-A) generated from lymphoblasts of three apparently healthy individuals

Germline-Competent Mouse-Induced Pluripotent Stem Cell Lines Generated on Human Fibroblasts Without Exogenous Leukemia Inhibitory Factor

Derivation of two induced pluripotent stem cell lines from a healthy control subject

Generation of a Human Induced Pluripotent Stem Cell Line from a 65-Year Old Healthy Female Donor with Chinese Han Genetic Background

Induced Pluripotent Stem Cell Line (Zzuneui011-A) Derived from Peripheral Blood Mononuclear Cells (pbmcs) of a Healthy 27-Year-old Female Individual.

Generation of a Human Induced Pluripotent Stem Cell Line (Shupli002-A) from PBMCs of a Healthy Female Donor

Establishment of an Induced Pluripotent Stem Cell Line (Sdchi011-A) from a Healthy Chinese Female Donor

An Induced Pluripotent Stem Cell Line (Csui004-A) from Skin Fibroblasts of a Healthy Individual

Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells

Efficient Derivation and Genetic Modifications of Human Pluripotent Stem Cells on Engineered Human Feeder Cell Lines.

Variations in humanized and defined culture conditions supporting derivation of new human embryonic stem cell lines

Derivation of Human Embryonic Stem Cell Lines from Parthenogenetic Blastocysts

Derivation and characterization of four new human embryonic stem cell lines: the Danish experience

Generation of a Human Induced Pluripotent Stem Cell Line (Shupli001-A) from PBMCs of a Healthy Male Donor.

Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences